Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers

Seungpyo Hong; Andrew Z. Wang

doi:10.1016/j.addr.2018.04.014

Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers

Seungpyo Hong, Andrew Z. Wang

Department of Pharmacy

Research output: Contribution to journal › Editorial › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	1-2
Number of pages	2
Journal	Advanced Drug Delivery Reviews
Volume	125
DOIs	https://doi.org/10.1016/j.addr.2018.04.014
Publication status	Published - 2018 Feb 1

All Science Journal Classification (ASJC) codes

Pharmaceutical Science

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.addr.2018.04.014

Cite this

@article{9a4e05b6cca54c7e89b0dbf2bd711b92,

title = "Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers",

author = "Seungpyo Hong and Wang, {Andrew Z.}",

year = "2018",

month = feb,

day = "1",

doi = "10.1016/j.addr.2018.04.014",

language = "English",

volume = "125",

pages = "1--2",

journal = "Advanced Drug Delivery Reviews",

issn = "0169-409X",

publisher = "Elsevier",

}

TY - JOUR

T1 - Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers

AU - Hong, Seungpyo

AU - Wang, Andrew Z.

PY - 2018/2/1

Y1 - 2018/2/1

UR - http://www.scopus.com/inward/record.url?scp=85048508599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048508599&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2018.04.014

DO - 10.1016/j.addr.2018.04.014

M3 - Editorial

C2 - 29880212

AN - SCOPUS:85048508599

SN - 0169-409X

VL - 125

SP - 1

EP - 2

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

ER -

Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this